Phase 1 12 trials
Phase 1
NCT02546661 Dec 2016 → Mar 2020 overdue infiltrating bladder urothelial carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 1
NCT02619864 Dec 2016 → Mar 2019 glioblastoma Canadian Cancer Trials Group
Completed
No outcome recorded
Phase 1
NCT02780830 Jun 2016 → Apr 2019 diffuse large B-cell lymphoma activated B-cell type , relapsed/refractory diffuse large B-cell lymphoma AstraZeneca
Withdrawn
No outcome recorded
Phase 1
NCT02640755 Jan → Dec 2016 cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT02599714 Dec 2015 → Mar 2018 breast cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT02398747 Mar 2015 → Apr 2024 high grade malignant neoplasm AstraZeneca
Completed
No outcome recorded
Phase 1
NCT02208375 Nov 2014 → Jun 2028 expected BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , endometrium adenocarcinoma , fallopian tube carcinoma +4 M.D. Anderson Cancer Center
Active not recruiting
No outcome recorded
Phase 1
NCT02064608 Oct 2014 → Dec 2016 prostate cancer Cambridge University Hospitals NHS Foundation Trust
Completed
No outcome recorded
Phase 1
NCT01884285 Jul 2013 → Mar 2019 castration-resistant prostate carcinoma , non-small cell squamous lung carcinoma , triple-negative breast carcinoma AstraZeneca
Completed
No outcome recorded
Phase 1
NCT02193633 Apr 2013 → Nov 2017 —
Royal Marsden NHS Foundation Trust
Completed
No outcome recorded
Phase 1
NCT01597388 May 2012 → Aug 2016 breast cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT01026402 Dec 2009 → Aug 2014 high grade malignant neoplasm AstraZeneca
Completed
No outcome recorded
Show 2 more trials Phase 1/2 5 trials
Phase 1/2
NCT03366103 Mar 2018 → Jul 2021 metastatic malignant neoplasm , small cell lung carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1/2
NCT03205046 Jun 2017 → Nov 2019 Richter transformation , diffuse large B-cell lymphoma Acerta Pharma BV
Terminated
No outcome recorded
Phase 1/2
NCT02813135 Aug 2016 → Feb 2031 expected childhood malignant neoplasm Gustave Roussy, Cancer Campus, Grand Paris
Recruiting
No outcome recorded
Phase 1/2
NCT02730923 Apr 2016 → Nov 2019 endometrial carcinoma , hormone receptor-positive breast cancer , metastatic carcinoma Centre Leon Berard
Unknown
No outcome recorded
Phase 1/2
NCT02583542 Jun 2015 → Mar 2020 non-small cell lung carcinoma , squamous cell lung carcinoma , triple-negative breast carcinoma Queen Mary University of London
Unknown
No outcome recorded
Phase 2 16 trials
Phase 2
NCT06727357 Sep 2019 → Mar 2025 overdue breast cancer European Institute of Oncology
Active not recruiting
No outcome recorded
Phase 2
NCT03166176 Mar → Jul 2018 cancer Samsung Medical Center
Withdrawn
No outcome recorded
Phase 2
NCT03166904 Mar → Jun 2018 cancer Samsung Medical Center
Withdrawn
No outcome recorded
Phase 2
NCT03334617 Dec 2017 → Sep 2024 overdue non-small cell lung carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 2
NCT03071874 Oct 2017 → Jun 2022 meningioma Massachusetts General Hospital
Unknown
No outcome recorded
Phase 2
NCT03106155 Aug 2017 → May 2018 small cell lung carcinoma Samsung Medical Center
Terminated
No outcome recorded
Phase 2
NCT03061708 Feb 2017 → Nov 2018 gastric neoplasm Samsung Medical Center
Terminated
No outcome recorded
Phase 2
NCT03082833 Feb 2017 → Nov 2018 gastric cancer Samsung Medical Center
Terminated
No outcome recorded
Phase 2
NCT02831257 Aug 2016 → May 2019 NF2-related schwannomatosis , meningioma Massachusetts General Hospital
Completed
No outcome recorded
Phase 2
NCT02752204 Oct 2015 → Sep 2017 diffuse large B-cell lymphoma University of Birmingham
Completed
No outcome recorded
Phase 2
NCT02664935 May 2015 → Nov 2023 adenocarcinoma , non-small cell lung carcinoma , squamous cell carcinoma University of Birmingham
Completed
No outcome recorded
Phase 2
NCT02403895 Apr 2015 → Dec 2016 non-small cell squamous lung carcinoma AstraZeneca
Terminated
No outcome recorded
Phase 2
NCT02117167 Apr 2014 → Dec 2018 non-small cell lung carcinoma UNICANCER
Completed
No outcome recorded
Phase 2
NCT02299999 Apr 2014 → Dec 2022 overdue breast cancer UNICANCER
Active not recruiting
No outcome recorded
Phase 2
NCT02216786 Jan 2014 → Dec 2021 estrogen-receptor positive breast cancer Queen Mary University of London
Completed
No outcome recorded
Phase 2
NCT01793636 Feb 2013 → May 2014 clear cell renal carcinoma Queen Mary University of London
Terminated
No outcome recorded
Show 6 more trials